Renal Denervation in the Real World: Practical Guidance for New Users

Published: 21 March 2022
Likes: 25
Average (rating)
No ratings
Your rating

Overview

During this unique broadcast, Radcliffe Medical Education brings together a globally-renowned European and American faculty to share best practices on resistant hypertension and renal denervation (RDN). If you manage patients with resistant hypertension – whether you treat directly or regularly refer patients to hypertension specialist services – this expert guidance will distil the most important practical points on identifying candidates for RDN. The aims of this broadcast are to draw attention to the current scale of resistant hypertension in the hypertensive population and to impart a sound understanding on appropriate patient selection for RDN.

Prof Roland Schmieder (University Hospital Erlangen, DE) leads proceedings, and is joined by Prof Michel Burnier (University Hospital of Lausanne, CH), Prof Cara East (Texas A&M College of Medicine, US) and Prof Konstantinos Tsioufis (University of Athens, GR) for a series of insightful presentations, discussions and live Q&A.

This broadcast is supported by an unrestricted educational grant from Medtronic.

Learning Objectives

  • Assess the current global burden of resistant hypertension
  • Carry out appropriate assessments to identify resistant hypertension
  • Identify patients most likely to benefit from RDN
  • Recall the practical considerations for adopting RDN into routine practice
  • Recall the latest data on RDN from recent clinical trials

Audience

  • Interventionalists
  • Nephrologists
  • Specialists engaged in treating hypertension
  • General Practitioners
  • General Cardiologists

Agenda

Introduction – Roland Schmieder

What Is the Place of RDN Today? – Konstantinos Tsioufis

- Which populations may derive benefit from RDN?
- Summary of trial data to date that support this

Summary of Best Practices: Captured From the Working Group – Cara East

- Aims of the working group
- Agreed set of principles
- Areas of potential differences between US and Europe

What Can Be Expected on RDN in the Future? – Michel Burnier

- Future position statements (ESH/AHA) and guidelines
- Future studies
- Working group publication

Discussion / live Q&A – All, moderated Roland Schmieder

Close – Roland Schmieder

This broadcast is supported by an unrestricted educational grant from Medtronic.